Judge Limits Stanford Doctor's Testimony In Opioid MDL

By Jonathan Capriel · September 20, 2021, 5:16 PM EDT

An Ohio federal judge narrowed what a Stanford University doctor will be allowed to testify about when it comes to aspects of opioid pharmacy operations during an upcoming bellwether trial, but...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022

Recent Articles By Jonathan

November 25, 2024
5th Circ. Upholds Miss. Ban On Medical Pot Ads
November 14, 2024
NY Nursing Homes Ink $45M Deal To End AG's Fraud Suit
October 16, 2024
SEC To Settle Claims CBD Exec Took $13M From Hospital
October 15, 2024
Conn. Medical Group Hit With $30M Verdict In C-Section Suit
September 04, 2024
Albertsons Denied Texas Court Remand In Opioid MDL
May 29, 2024
5th Circ. Sends Hain Toxic Baby Food Suit To State Court
May 02, 2024
Biden Announces $3B To Fund Lead Pipe Replacement
April 30, 2024
BCBS Says Federal Drug Law Preempts NM Medical Weed Row
April 24, 2024
Pa. Court Revives Malpractice Suit Over Hip Implant Surgeries
April 16, 2024
Amazon Beats Suit After Injured Drivers Bury Medical Details